FDA approves Fayuvi (rebisufligene etisparvovec-hopf), the first gene therapy for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA).

High pulse pressure and low education levels significantly worsen amyloid-related cognitive decline in adults aged 90 years and older.

High serum glial fibrillary acidic protein levels indicate an increased risk for progression independent of relapse activity in multiple sclerosis.

The FDA approved Isembyld (apitegromab-mstn) for adults and pediatric patients aged 2 years and older with spinal muscular atrophy (SMA) receiving SMN2-targeted therapy.

Adults with chronic cough exhibited significant reductions in GMV across multiple brain regions when compared with a healthy control group.

A recent study of people with autism spectrum disorder and covered by Medicaid found that people with autism have a shorter life expectancy.

High levels of adolescent vaccination coverage continued through 2025, but study authors recognize a need for further and more consistent coverage.

Relatively few adults report discussing vascular health with a health care provider despite the prevalence of vascular disease in the US.

As more people are exposed to rabid or possibly rabid animals, the CDC advises anyone bit or scratched by an animal to seek care immediately.

This is a syndicated post stub. Neurology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical ...